Hypothesis: The surgeon can contribute substantially to the long-term survi
val rate of patients undergoing hepatectomy for hepatocellular carcinoma (H
CC).
Design: The long-term survival rate of patients with HCC undergoing hepatec
tomy has improved, but the contribution of the surgeon to the improved surv
ival rate is unknown. We surveyed 211 consecutive patients undergoing hepat
ectomy for HCC. The clinical, operative , and pathological factors were ana
lyzed to identify factors that were important in affecting long-term surviv
al.
Setting: A tertiary referral center.
Patients: From April 1989 to December 1995, 211 consecutive patients with H
CC underwent 153 major and 58 minor hepatectomies.
Main Outcome Measures: Disease-free and overall cumulative survival rate.
Results: The 5-year disease-free survival rate was 27% By Cox regression an
alysis, blood transfusion (relative risk [RR], 1.21; 95% confidence interva
l [Cl], 1.05-1.40) and TNM stage (RR, 1.90; 95% Cl, 1.47-2.47) were shown t
o be independent prognostic factors in the 5-year disease free survival rat
e. The 5-year overall cumulative survival rate was 37%. By Cox regression a
nalysis, the preoperative indocyanine green retention value at 15 minutes a
fter injection (RR, 1.03; 95% Cl, 1.01-1.06), blood transfusion (RR, 1.191;
95% Cl, 1.078-1.316), tumor rupture (RR, 1.48; 95% Cl, 1.08-2.04), and TNM
stage (RR, 1.62; 9596 Cl, 1.27-2.07) were shown to be significant independ
ent factors that influenced cumulative survival rate.
Conclusions: The long-term survival of patients with HCC after hepatectomy
depends on tumor staging, preoperative hepatic functional reserve e, histor
y of blood transfusion, and rupture of HCC. Preoperative liver function and
tumor staging cannot be altered; however, the surgeon can play an importan
t role in improving the prognosis if blood transfusion and iatrogenic tumor
rupture can be avoided and if function of the liver remnant can be preserv
ed.